EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

PHASE2CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Edematous Fibrosclerotic PanniculopathyCellulite
Interventions
BIOLOGICAL

COLLAGENASE CLOSTRIDIUM HISTOLYTICUM

Injectable intervention

BIOLOGICAL

Placebo Comparator

Trial Locations (16)

10065

Bass Plastic Surgery, PLLC, New York

10075

Mercy Health Research, Washington

Sadick Research Group, New York

22911

Charlottesville Medical Research Center LLC, Charlottesville

24501

The Education & Research Foundation, Lynchburg

27262

Dermatology Consulting Services, High Point

33146

Skin Research Institute LLC, Coral Gables

33401

Research Institute of the Southeast, West Palm Beach

33756

Olympian Clinical Research, Clearwater

37215

Tennessee Clinical Research Center, Nashville

78660

Austin Institute for Clinical Research, Pflugerville

90210

Clinical Testing of Beverly Hills, Beverly Hills

92056

Dermatology Specialists, Inc, Oceanside

92121

Dermatology Cosmetic Laser Medical Associates of LaJolla, Inc, San Diego

92562

Dermatology Specialists, Inc, Murrieta

99202

Premier Clinical Research, Spokane

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY